Appointment booking for Dr. Donna Maneice, MD is currently not available.Dr. Donna Maneice, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Donna Maneice, MD (she/her) is a Rheumatologist in Tuscaloosa, AL with over 18 years of experience. What is your opinion of Dr. Donna Maneice, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Donna Maneice, MD has received over $10,710 which includes payments from the following companies:
$1,640.43 from Amgen Inc.
$1,172.42 from AbbVie, Inc.
$1,115.96 from Pfizer Inc.
$962.53 from Novartis Pharmaceuticals Corporation
$735.34 from UCB, Inc.
$678.70 from E.R. Squibb & Sons, L.L.C.
$533.93 from Genentech USA, Inc.
$511.31 from Horizon Pharma plc
$483.44 from Janssen Biotech, Inc.
$381.55 from GlaxoSmithKline, LLC.
$338.16 from Celgene Corporation
$334.06 from Mallinckrodt LLC
$296.68 from LILLY USA, LLC
$261.70 from Regeneron Healthcare Solutions, Inc.
$237.46 from Mallinckrodt Hospital Products Inc.
$211.19 from Mallinckrodt Enterprises LLC
$134.49 from Janssen Scientific Affairs, LLC
$119.94 from Janssen Pharmaceuticals, Inc
$115.13 from Radius Health, Inc.
$58.88 from Purdue Pharma L.P.
Payments received by Dr. Donna Maneice, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!